Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Inhibition of prostate cancer proliferation by Deferiprone.

Simões RV, Veeraperumal S, Serganova IS, Kruchevsky N, Varshavsky J, Blasberg RG, Ackerstaff E, Koutcher JA.

NMR Biomed. 2017 Jun;30(6). doi: 10.1002/nbm.3712. Epub 2017 Mar 8.

2.

Tumor stroma interaction is mediated by monocarboxylate metabolism.

Patel BB, Ackerstaff E, Serganova IS, Kerrigan JE, Blasberg RG, Koutcher JA, Banerjee D.

Exp Cell Res. 2017 Mar 1;352(1):20-33. doi: 10.1016/j.yexcr.2017.01.013. Epub 2017 Jan 26.

3.

Synthesis and evaluation of an (18)F-labeled pyrimidine-pyridine amine for targeting CXCR4 receptors in gliomas.

Demoin DW, Shindo M, Zhang H, Edwards KJ, Serganova I, Pillarsetty NV, Lewis JS, Blasberg RG.

Nucl Med Biol. 2016 Oct;43(10):606-11. doi: 10.1016/j.nucmedbio.2016.05.005. Epub 2016 May 14.

4.

Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment.

Simões RV, Serganova IS, Kruchevsky N, Leftin A, Shestov AA, Thaler HT, Sukenick G, Locasale JW, Blasberg RG, Koutcher JA, Ackerstaff E.

Neoplasia. 2015 Aug;17(8):671-84. doi: 10.1016/j.neo.2015.08.005.

5.

Surface-enhanced resonance Raman scattering nanostars for high-precision cancer imaging.

Harmsen S, Huang R, Wall MA, Karabeber H, Samii JM, Spaliviero M, White JR, Monette S, O'Connor R, Pitter KL, Sastra SA, Saborowski M, Holland EC, Singer S, Olive KP, Lowe SW, Blasberg RG, Kircher MF.

Sci Transl Med. 2015 Jan 21;7(271):271ra7. doi: 10.1126/scitranslmed.3010633.

6.

Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer.

Viola-Villegas NT, Carlin SD, Ackerstaff E, Sevak KK, Divilov V, Serganova I, Kruchevsky N, Anderson M, Blasberg RG, Andreev OA, Engelman DM, Koutcher JA, Reshetnyak YK, Lewis JS.

Proc Natl Acad Sci U S A. 2014 May 20;111(20):7254-9. doi: 10.1073/pnas.1405240111. Epub 2014 May 1.

7.

Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.

Zhang H, Huang R, Cheung NK, Guo H, Zanzonico PB, Thaler HT, Lewis JS, Blasberg RG.

Clin Cancer Res. 2014 Apr 15;20(8):2182-91. doi: 10.1158/1078-0432.CCR-13-1153. Epub 2014 Feb 26.

8.

Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter.

Zhang H, Huang R, Pillarsetty N, Thorek DL, Vaidyanathan G, Serganova I, Blasberg RG, Lewis JS.

Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):322-32. doi: 10.1007/s00259-013-2558-9. Epub 2013 Oct 31.

9.

Molecular imaging of expression of vascular endothelial growth factor a (VEGF a) in femoral bone grafts transplanted into living mice.

Strachna O, Torrecilla D, Reumann MK, Serganova I, Kim J, Gieschler S, Boskey AL, Blasberg RG, Mayer-Kuckuk P.

Cell Transplant. 2014;23(7):901-12. doi: 10.3727/096368912X667015. Epub 2013 Apr 12.

10.

Noninvasive molecular imaging using reporter genes.

Brader P, Serganova I, Blasberg RG.

J Nucl Med. 2013 Feb;54(2):167-72. doi: 10.2967/jnumed.111.099788. Epub 2013 Jan 14. Review.

11.

Integrin αvβ3-targeted IRDye 800CW near-infrared imaging of glioblastoma.

Huang R, Vider J, Kovar JL, Olive DM, Mellinghoff IK, Mayer-Kuckuk P, Kircher MF, Blasberg RG.

Clin Cancer Res. 2012 Oct 15;18(20):5731-40. doi: 10.1158/1078-0432.CCR-12-0374. Epub 2012 Aug 22.

12.

Monitoring the induction of heat shock factor 1/heat shock protein 70 expression following 17-allylamino-demethoxygeldanamycin treatment by positron emission tomography and optical reporter gene imaging.

Doubrovin M, Che JT, Serganova I, Moroz E, Solit DB, Ageyeva L, Kochetkova T, Pillarsetti N, Finn R, Rosen N, Blasberg RG.

Mol Imaging. 2012 Feb;11(1):67-76.

13.

MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas.

Huang R, Cheung NK, Vider J, Cheung IY, Gerald WL, Tickoo SK, Holland EC, Blasberg RG.

FASEB J. 2011 Dec;25(12):4138-49. doi: 10.1096/fj.11-185033. Epub 2011 Aug 19.

14.
15.

Comparison of corticotropin-releasing factor, dexamethasone, and temozolomide: treatment efficacy and toxicity in U87 and C6 intracranial gliomas.

Moroz MA, Huang R, Kochetkov T, Shi W, Thaler H, de Stanchina E, Gamez I, Ryan RP, Blasberg RG.

Clin Cancer Res. 2011 May 15;17(10):3282-92. doi: 10.1158/1078-0432.CCR-10-3203. Epub 2011 Mar 8.

16.

Imaging colon cancer response following treatment with AZD1152: a preclinical analysis of [18F]fluoro-2-deoxyglucose and 3'-deoxy-3'-[18F]fluorothymidine imaging.

Moroz MA, Kochetkov T, Cai S, Wu J, Shamis M, Nair J, de Stanchina E, Serganova I, Schwartz GK, Banerjee D, Bertino JR, Blasberg RG.

Clin Cancer Res. 2011 Mar 1;17(5):1099-110. doi: 10.1158/1078-0432.CCR-10-1430. Epub 2011 Jan 18.

17.

Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors.

Escorcia FE, Henke E, McDevitt MR, Villa CH, Smith-Jones P, Blasberg RG, Benezra R, Scheinberg DA.

Cancer Res. 2010 Nov 15;70(22):9277-86. doi: 10.1158/0008-5472.CAN-10-2029. Epub 2010 Nov 2.

18.

Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo.

Na IK, Markley JC, Tsai JJ, Yim NL, Beattie BJ, Klose AD, Holland AM, Ghosh A, Rao UK, Stephan MT, Serganova I, Santos EB, Brentjens RJ, Blasberg RG, Sadelain M, van den Brink MR.

Blood. 2010 Sep 16;116(11):e18-25. doi: 10.1182/blood-2009-12-259432. Epub 2010 May 28.

19.

Plasma protein binding of luciferase substrates influences sensitivity and accuracy of bioluminescence imaging.

Keyaerts M, Heneweer C, Gainkam LO, Caveliers V, Beattie BJ, Martens GA, Vanhove C, Bossuyt A, Blasberg RG, Lahoutte T.

Mol Imaging Biol. 2011 Feb;13(1):59-66. doi: 10.1007/s11307-010-0325-x.

PMID:
20383591
20.

Apparent diffusion coefficient of glial neoplasms: correlation with fluorodeoxyglucose-positron-emission tomography and gadolinium-enhanced MR imaging.

Holodny AI, Makeyev S, Beattie BJ, Riad S, Blasberg RG.

AJNR Am J Neuroradiol. 2010 Jun;31(6):1042-8. doi: 10.3174/ajnr.A1989. Epub 2010 Feb 11.

21.

Different strategies for reducing intestinal background radioactivity associated with imaging HSV1-tk expression using established radionucleoside probes.

Ruggiero A, Brader P, Serganova I, Zanzonico P, Cai S, Lipman NS, Hricak H, Blasberg RG.

Mol Imaging. 2010 Feb;9(1):47-58.

22.

Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene.

Brader P, Kelly KJ, Chen N, Yu YA, Zhang Q, Zanzonico P, Burnazi EM, Ghani RE, Serganova I, Hricak H, Szalay AA, Fong Y, Blasberg RG.

Clin Cancer Res. 2009 Jun 1;15(11):3791-801. doi: 10.1158/1078-0432.CCR-08-3236. Epub 2009 May 26.

23.

Registration of planar bioluminescence to magnetic resonance and x-ray computed tomography images as a platform for the development of bioluminescence tomography reconstruction algorithms.

Beattie BJ, Klose AD, Le CH, Longo VA, Dobrenkov K, Vider J, Koutcher JA, Blasberg RG.

J Biomed Opt. 2009 Mar-Apr;14(2):024045. doi: 10.1117/1.3120495.

24.

Imaging of lymph node micrometastases using an oncolytic herpes virus and [F]FEAU PET.

Brader P, Kelly K, Gang S, Shah JP, Wong RJ, Hricak H, Blasberg RG, Fong Y, Gil Z.

PLoS One. 2009;4(3):e4789. doi: 10.1371/journal.pone.0004789. Epub 2009 Mar 10.

25.

Imaging transgene activity in vivo.

Gade TP, Koutcher JA, Spees WM, Beattie BJ, Ponomarev V, Doubrovin M, Buchanan IM, Beresten T, Zakian KL, Le HC, Tong WP, Mayer-Kuckuk P, Blasberg RG, Gelovani JG.

Cancer Res. 2008 Apr 15;68(8):2878-84. doi: 10.1158/0008-5472.CAN-07-6028.

26.

Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas.

Becher OJ, Hambardzumyan D, Fomchenko EI, Momota H, Mainwaring L, Bleau AM, Katz AM, Edgar M, Kenney AM, Cordon-Cardo C, Blasberg RG, Holland EC.

Cancer Res. 2008 Apr 1;68(7):2241-9. doi: 10.1158/0008-5472.CAN-07-6350.

27.

Imaging of HSV-tk Reporter gene expression: comparison between [18F]FEAU, [18F]FFEAU, and other imaging probes.

Miyagawa T, Gogiberidze G, Serganova I, Cai S, Balatoni JA, Thaler HT, Ageyeva L, Pillarsetty N, Finn RD, Blasberg RG.

J Nucl Med. 2008 Apr;49(4):637-48. doi: 10.2967/jnumed.107.046227. Epub 2008 Mar 14.

28.

Imaging update: new windows, new views.

Blasberg RG.

Clin Cancer Res. 2007 Jun 15;13(12):3444-8. Review. No abstract available.

29.

Imaging hNET reporter gene expression with 124I-MIBG.

Moroz MA, Serganova I, Zanzonico P, Ageyeva L, Beresten T, Dyomina E, Burnazi E, Finn RD, Doubrovin M, Blasberg RG.

J Nucl Med. 2007 May;48(5):827-36.

30.

Multimodality registration without a dedicated multimodality scanner.

Beattie BJ, Förster GJ, Govantes R, Le CH, Longo VA, Zanzonico PB, Bidaut L, Blasberg RG, Koutcher JA.

Mol Imaging. 2007 Mar-Apr;6(2):108-20.

PMID:
17445505
31.

Multi-modality molecular imaging of tumors.

Serganova I, Blasberg RG.

Hematol Oncol Clin North Am. 2006 Dec;20(6):1215-48.

PMID:
17113460
32.
33.

Molecular imaging reveals skeletal engraftment sites of transplanted bone marrow cells.

Mayer-Kuckuk P, Doubrovin M, Bidaut L, Budak-Alpdogan T, Cai S, Hubbard V, Alpdogan O, van den Brink M, Bertino JR, Blasberg RG, Banerjee D, Gelovani J.

Cell Transplant. 2006;15(1):75-82.

PMID:
16700332
34.

[131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity.

Zanzonico P, Koehne G, Gallardo HF, Doubrovin M, Doubrovina E, Finn R, Blasberg RG, Riviere I, O'Reilly RJ, Sadelain M, Larson SM.

Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):988-97. Epub 2006 Apr 11.

PMID:
16607546
35.

Imaging herpes viral thymidine kinase-1 reporter gene expression with a new 18F-labeled probe: 2'-fluoro-2'-deoxy-5-[18F]fluoroethyl-1-beta-d-arabinofuranosyl uracil.

Balatoni JA, Doubrovin M, Ageyeva L, Pillarsetty N, Finn RD, Gelovani JG, Blasberg RG.

Nucl Med Biol. 2005 Nov;32(8):811-9.

PMID:
16253805
36.

High-resolution imaging of bone precursor cells within the intact bone marrow cavity of living mice.

Mayer-Kuckuk P, Gade TP, Buchanan IM, Doubrovin M, Ageyeva L, Bertino JR, Boskey AL, Blasberg RG, Koutcher JA, Banerjee D.

Mol Ther. 2005 Jul;12(1):33-41.

37.

Multimodality in vivo molecular-genetic imaging.

Doubrovin M, Serganova I, Mayer-Kuckuk P, Ponomarev V, Blasberg RG.

Bioconjug Chem. 2004 Nov-Dec;15(6):1376-88. Review.

PMID:
15546205
38.

PET-based reporter gene imaging. Assessment of endogenous molecular-genetic events.

Doubrovin M, Ponomarev V, Blasberg RG.

IEEE Eng Med Biol Mag. 2004 Jul-Aug;23(4):38-50. Review. No abstract available.

PMID:
15508384
39.

Role of reporter gene imaging in molecular and cellular biology.

Mayer-Kuckuk P, Menon LG, Blasberg RG, Bertino JR, Banerjee D.

Biol Chem. 2004 May;385(5):353-61. Review.

PMID:
15195994
40.

In vivo molecular-genetic imaging: multi-modality nuclear and optical combinations.

Blasberg RG.

Nucl Med Biol. 2003 Nov;30(8):879-88. Review.

PMID:
14698792
41.

Development of a new reporter gene system--dsRed/xanthine phosphoribosyltransferase-xanthine for molecular imaging of processes behind the intact blood-brain barrier.

Doubrovin M, Ponomarev V, Serganova I, Soghomonian S, Myagawa T, Beresten T, Ageyeva L, Sadelain M, Koutcher J, Blasberg RG, Tjuvajev JG.

Mol Imaging. 2003 Apr;2(2):93-112.

PMID:
12964307
42.

Molecular-genetic imaging: a nuclear medicine-based perspective.

Blasberg RG, Gelovani J.

Mol Imaging. 2002 Jul;1(3):280-300. Review.

PMID:
12920854
43.

Molecular-genetic imaging: current and future perspectives.

Blasberg RG, Tjuvajev JG.

J Clin Invest. 2003 Jun;111(11):1620-9. Review. No abstract available.

44.

In vivo imaging of molecular-genetic targets for cancer therapy.

Gelovani Tjuvajev J, Blasberg RG.

Cancer Cell. 2003 Apr;3(4):327-32. Review. No abstract available.

45.

Molecular imaging and cancer.

Blasberg RG.

Mol Cancer Ther. 2003 Mar;2(3):335-43. Review.

46.

Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes.

Koehne G, Doubrovin M, Doubrovina E, Zanzonico P, Gallardo HF, Ivanova A, Balatoni J, Teruya-Feldstein J, Heller G, May C, Ponomarev V, Ruan S, Finn R, Blasberg RG, Bornmann W, Riviere I, Sadelain M, O'Reilly RJ, Larson SM, Tjuvajev JG.

Nat Biotechnol. 2003 Apr;21(4):405-13. Epub 2003 Mar 24.

PMID:
12652311
47.

In vivo molecular-genetic imaging.

Blasberg RG, Gelovani-Tjuvajev J.

J Cell Biochem Suppl. 2002;39:172-83. Review.

PMID:
12552617
48.

Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression.

Tjuvajev JG, Doubrovin M, Akhurst T, Cai S, Balatoni J, Alauddin MM, Finn R, Bornmann W, Thaler H, Conti PS, Blasberg RG.

J Nucl Med. 2002 Aug;43(8):1072-83.

49.

Tumor-specific transcriptional targeting of suicide gene therapy.

Qiao J, Doubrovin M, Sauter BV, Huang Y, Guo ZS, Balatoni J, Akhurst T, Blasberg RG, Tjuvajev JG, Chen SH, Woo SL.

Gene Ther. 2002 Feb;9(3):168-75.

50.

Receptor binding radiotracers: personal history of the past 20 years.

Blasberg RG.

Nucl Med Biol. 2001 Jul;28(5):573-83. Review. No abstract available.

PMID:
11516701

Supplemental Content

Loading ...
Support Center